At The Psychedelic Healthcare Forum, co-hosted by Psychedelic Alpha and Horizons in New York on October 15th, we dedicated a significant portion of our afternoon programming to a question that has loomed large in the field of late: Once a psychedelic is approved, how does it actually reach patients, and who pays? The block was moderated by Jazz Glastra, Senior Director at BrainFutures…

Source

Previous articleWeekly Psychedelic Policy Briefing, Nov 13, 2026